Resmed Inc. buy UBS Group AG
Start price
20.09.25
/
50%
€234.30
Target price
20.09.26
-
Performance (%)
-1.41%
Price
01.10.25
€231.00
Summary
This prediction is currently active. With a performance of -1.41%, the BUY prediction for Resmed Inc. by UBS_Group_AG is down slightly. This prediction currently runs until 20.09.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Resmed Inc. | -1.113% |
| iShares Core DAX® | 2.304% |
| iShares Nasdaq 100 | 1.287% |
| iShares Nikkei 225® | 0.404% |
| iShares S&P 500 | 1.202% |
Comments by UBS_Group_AG for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Ratings data for RMD provided by MarketBeat